Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066703 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2672

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: exemestane
DRUG: tamoxifen
DRUG: triptorelin

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]
[object Object]